AN2 Therapeutics (ANTX) Payables (2021 - 2026)
AN2 Therapeutics' Payables came in at $1.97 million for Q2 2026, down 6.9% from $2.11 million a year earlier and down 24.8% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics' Payables was $3.02 million, down 8.9% from FY2024.
- Payables carries a four-year compound annual growth rate of 29.8% (FY2021 to FY2025).
- Going back by year, Payables was $3.32 million in FY2024 (+24.0%), $2.68 million in FY2023 (+26.1%), $2.12 million in FY2022 (+99.6%) and $1.06 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Payables since Q3 2024.
- Year-over-year, Payables has declined for three consecutive quarters, with an average decline of 0.4% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q3 2023 (growth of 238.7%), and the weakest in Q3 2024 (a decline of 64.9%).
- Business Quant data shows ANTX's Payables at $2.62 million (Q1 2026), $3.02 million (Q4 2025) and $2.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | AN2 Therapeutics | 181.91 Mn | 181.91 Mn | - | 1.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 4.88 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 1.06 Mn |
API Access
AN2 Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();